Barrow Hanley Mewhinney & Strauss LLC cut its stake in CVS Health Corp (NYSE:CVS) by 4.9% in the 3rd quarter, HoldingsChannel reports. The fund owned 16,207,787 shares of the pharmacy operator’s stock after selling 836,333 shares during the period. CVS Health accounts for approximately 2.0% of Barrow Hanley Mewhinney & Strauss LLC’s holdings, making the stock its 18th largest holding. Barrow Hanley Mewhinney & Strauss LLC’s holdings in CVS Health were worth $1,318,017,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the company. Jackson Grant Investment Advisers Inc. boosted its holdings in CVS Health by 0.6% during the second quarter. Jackson Grant Investment Advisers Inc. now owns 2,881 shares of the pharmacy operator’s stock worth $232,000 after buying an additional 18 shares in the last quarter. Traynor Capital Management Inc. boosted its holdings in CVS Health by 1.3% during the second quarter. Traynor Capital Management Inc. now owns 3,676 shares of the pharmacy operator’s stock worth $290,000 after buying an additional 48 shares in the last quarter. Sequoia Financial Advisors LLC boosted its holdings in CVS Health by 0.8% during the second quarter. Sequoia Financial Advisors LLC now owns 6,406 shares of the pharmacy operator’s stock worth $515,000 after buying an additional 53 shares in the last quarter. Brookstone Capital Management boosted its holdings in CVS Health by 1.8% during the second quarter. Brookstone Capital Management now owns 3,153 shares of the pharmacy operator’s stock worth $254,000 after buying an additional 55 shares in the last quarter. Finally, Summit Asset Management LLC boosted its holdings in CVS Health by 2.0% during the second quarter. Summit Asset Management LLC now owns 5,172 shares of the pharmacy operator’s stock worth $416,000 after buying an additional 100 shares in the last quarter. Institutional investors and hedge funds own 80.81% of the company’s stock.

In other CVS Health news, EVP Lisa Bisaccia sold 29,445 shares of the stock in a transaction that occurred on Thursday, December 21st. The shares were sold at an average price of $75.00, for a total value of $2,208,375.00. Following the completion of the sale, the executive vice president now owns 15,556 shares in the company, valued at approximately $1,166,700. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.61% of the stock is owned by corporate insiders.

Shares of CVS Health Corp (NYSE CVS) opened at $69.79 on Thursday. CVS Health Corp has a 12-month low of $66.45 and a 12-month high of $84.00. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.02 and a quick ratio of 0.52. The stock has a market cap of $70,700.00, a P/E ratio of 11.83, a price-to-earnings-growth ratio of 1.18 and a beta of 0.92.

CVS Health (NYSE:CVS) last released its earnings results on Thursday, February 8th. The pharmacy operator reported $1.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.88 by $0.04. CVS Health had a net margin of 3.58% and a return on equity of 17.21%. The company had revenue of $48.39 billion during the quarter, compared to the consensus estimate of $47.54 billion. During the same quarter in the prior year, the firm earned $1.71 EPS. The company’s revenue was up 5.3% compared to the same quarter last year. equities analysts expect that CVS Health Corp will post 6.44 earnings per share for the current year.

The business also recently announced a quarterly dividend, which was paid on Friday, February 2nd. Shareholders of record on Wednesday, January 24th were given a $0.50 dividend. The ex-dividend date was Tuesday, January 23rd. This represents a $2.00 dividend on an annualized basis and a yield of 2.87%. CVS Health’s payout ratio is 33.90%.

Several brokerages recently commented on CVS. Loop Capital reduced their price target on shares of CVS Health from $83.00 to $73.00 and set a “hold” rating for the company in a research report on Tuesday, November 7th. Morgan Stanley upgraded shares of CVS Health from an “equal weight” rating to an “overweight” rating and set a $88.00 price target for the company in a research report on Friday, January 5th. Needham & Company LLC upped their price target on shares of CVS Health from $85.00 to $88.00 and gave the company a “buy” rating in a research report on Tuesday, January 2nd. SunTrust Banks upped their price target on shares of CVS Health to $90.00 and gave the company a “buy” rating in a research report on Friday, January 5th. Finally, Leerink Swann set a $85.00 price target on shares of CVS Health and gave the company a “buy” rating in a research report on Friday, February 9th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $87.82.

ILLEGAL ACTIVITY WARNING: This piece of content was published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The legal version of this piece of content can be viewed at https://theolympiareport.com/2018/02/15/cvs-health-corp-cvs-stake-lessened-by-barrow-hanley-mewhinney-strauss-llc.html.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.